Table 3 Clinical features of patients with confirmed neuroborreliosis, stratified into two groups depending on the IL-17 level in cerebrospinal fluid.
| Â | IL-17 in CSF <0.80 pg/mL n = 68 | IL-17 in CSF >0.80 pg/mL n = 65 |
|---|---|---|
Pleocytosis median number of cells/μL, (range) | 138 (8-384) | 184* (10-1650) |
CSF-albumin S-albumin median, (range) | 14.3 (3.4-59.6) | 18.1 (3.8-76.0) |
Median age years, (range) | 48 (3-87) | 14 (3-77) |
Median duration of symptoms before LP weeks, (range) | 2.0 (0.1-25.0) | 3.0 (0-32.0) |
Cranial nerve palsy n, (%) | 37 (54.4) | 33 (50.8) |
Muscle and joint pain n, (%) | 32 (47.1) | 27 (41.5) |
Radiculitis n, (%) | 30 (44.1) | 23 (35.4) |
Neck pain n, (%) | 22 (32.4) | 25 (38.5) |
Headache n, (%) | 26 (28.2) | 29 (44.6) |
Fatigue n, (%) | 17 (25.0) | 31* (47.7) |
Parestesias n, (%) | 12 (17.6) | 11 (16.9) |
Fever >38°C n, (%) | 10 (14.7) | 16 (24.6) |
Vertigo n, (%) | 4 (5.9) | 6 (9.2) |
Concentration difficulties n, (%) | 2 (2.9) | 2 (3.1) |